225 related articles for article (PubMed ID: 6130534)
41. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.
Lurie S; O'Quinn A
J Neuropsychiatry Clin Neurosci; 1991; 3(1):41-50. PubMed ID: 7580171
[TBL] [Abstract][Full Text] [Related]
42. Pemoline therapy in college students with attention deficit hyperactivity disorder: a retrospective study.
Heiligenstein E; Johnston HF; Nielsen JK
J Am Coll Health; 1996 Jul; 45(1):35-9. PubMed ID: 8708264
[TBL] [Abstract][Full Text] [Related]
43. Stimulant medications in adults with attention deficit disorder.
Gauthier M
Can J Psychiatry; 1984 Aug; 29(5):435-40. PubMed ID: 6148139
[TBL] [Abstract][Full Text] [Related]
44. Stimulant medication and parent training therapies for attention deficit-hyperactivity disorder.
Anastopoulos AD; DuPaul GJ; Barkley RA
J Learn Disabil; 1991 Apr; 24(4):210-8. PubMed ID: 1875156
[TBL] [Abstract][Full Text] [Related]
45. Medication for attention deficit hyperactivity disorder: commentary and response.
Faigel HC; Heiligenstein E
J Am Coll Health; 1996 Jul; 45(1):40-1; discussion 41-2. PubMed ID: 8708265
[No Abstract] [Full Text] [Related]
46. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.
Greenhill LL; Pliszka S; Dulcan MK; Bernet W; Arnold V; Beitchman J; Benson RS; Bukstein O; Kinlan J; McClellan J; Rue D; Shaw JA; Stock S;
J Am Acad Child Adolesc Psychiatry; 2002 Feb; 41(2 Suppl):26S-49S. PubMed ID: 11833633
[TBL] [Abstract][Full Text] [Related]
47. Trends in the prescribing of stimulant medication for the treatment of Attention Deficit Hyperactivity Disorder in adults in New South Wales.
New South Wales Department of Health
N S W Public Health Bull; 2004; 15 Suppl 3():1-55. PubMed ID: 15448720
[No Abstract] [Full Text] [Related]
48. Dramatic favorable responses of children with learning disabilities or dyslexia and attention deficit disorder to antimotion sickness medications: four case reports.
Levinson HN
Percept Mot Skills; 1991 Dec; 73(3 Pt 1):723-38. PubMed ID: 1686492
[TBL] [Abstract][Full Text] [Related]
49. Medication and hyperactivity: a meta-analysis.
Thurber S; Walker CE
J Gen Psychol; 1983 Jan; 108(1st Half):79-86. PubMed ID: 6131929
[No Abstract] [Full Text] [Related]
50. Stimulant drugs for severe hyperactivity in childhood.
Drug Ther Bull; 2001 Jul; 39(7):52-4. PubMed ID: 11471516
[TBL] [Abstract][Full Text] [Related]
51. Stimulant medication in pre-school children in New South Wales.
Eysbouts Y; Poulton A; Salmelainen P
J Paediatr Child Health; 2011 Dec; 47(12):870-4. PubMed ID: 21658150
[TBL] [Abstract][Full Text] [Related]
52. Methylphenidate vs dexamphetamine: a clinical audit.
Green C
J Paediatr Child Health; 1996 Oct; 32(5):470. PubMed ID: 8933415
[No Abstract] [Full Text] [Related]
53. Sex subgroup analysis of treatment response to lisdexamfetamine dimesylate in children aged 6 to 12 years with attention-deficit/hyperactivity disorder.
McGough JJ; Greenbaum M; Adeyi B; Babcock T; Scheckner B; Dirks B; Findling RL
J Clin Psychopharmacol; 2012 Feb; 32(1):138-40. PubMed ID: 22217951
[No Abstract] [Full Text] [Related]
54. An update on attention deficit disorder.
Harv Ment Health Lett; 2004 May; 20(11):4-7. PubMed ID: 15153391
[No Abstract] [Full Text] [Related]
55. Stimulant treatment of bulimia nervosa with and without attention-deficit disorder: three case reports.
Drimmer EJ
Nutrition; 2003 Jan; 19(1):76-7. PubMed ID: 12507648
[No Abstract] [Full Text] [Related]
56. The challenges to demonstrating long-term effects of psychostimulant treatment for attention-deficit/hyperactivity disorder.
Hazell P
Curr Opin Psychiatry; 2011 Jul; 24(4):286-90. PubMed ID: 21519262
[TBL] [Abstract][Full Text] [Related]
57. The efficacy of stimulant drug treatment for hyperactivity: a meta-analysis.
Kavale K
J Learn Disabil; 1982 May; 15(5):280-9. PubMed ID: 6123539
[No Abstract] [Full Text] [Related]
58. Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults.
Castaneda R; Levy R; Hardy M; Trujillo M
Psychiatr Serv; 2000 Feb; 51(2):169-71. PubMed ID: 10654994
[No Abstract] [Full Text] [Related]
59. Effects of stimulant medication on learning in children with ADHD.
Swanson JM; Cantwell D; Lerner M; McBurnett K; Hanna G
J Learn Disabil; 1991 Apr; 24(4):219-30, 255. PubMed ID: 1875157
[TBL] [Abstract][Full Text] [Related]
60. Pemoline and urinary excretion of catecholamines and indoleamines in children with attention deficit disorder.
Zametkin AJ; Linnoila M; Karoum F; Sallee R
Am J Psychiatry; 1986 Mar; 143(3):359-62. PubMed ID: 2420216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
